ALLAN JONATHAN (GENERAL COUNSEL & CORP SEC) sold 38.3% of their position (9.80K shares) of STOKE THERAPEUTICS, INC. on the open market
Open‑market sale worth $306.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+6K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−824.00
Price / share
$30.76
Trade value
$25.35K
% of position
Common Stock
Shares
−194.00
Price / share
$31.32
Trade value
$6.08K
% of position
Common Stock
Shares
−1K
Price / share
$31.33
Trade value
$31.46K
% of position
Common Stock
Shares
−5.44K
Price / share
$31.08
Trade value
$169K
% of position
Common Stock
Shares
−2.34K
Price / share
$31.76
Trade value
$74.44K
% of position
Net shares
−3.80K
Net value
-$306.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/3/2025 | M · Option Exercise | +6K | — | — | 30.6% | 19.61K | 25.61K |
| Common Stock Direct | 12/4/2025 | S · Sale | −824.00 | $30.76 | $25.35K | 3.2% | 25.61K | 24.79K |
| Common Stock Direct | 12/4/2025 | S · Sale | −194.00 | $31.32 | $6.08K | 0.8% | 24.79K | 24.59K |
| Common Stock Direct | 12/5/2025 | S · Sale | −1K | $31.33 | $31.46K | 4.1% | 24.59K | 23.59K |
| Common Stock Direct | 12/5/2025 | S · Sale | −5.44K | $31.08 | $169K | 23.0% | 23.59K | 18.15K |
| Common Stock Direct | 12/5/2025 | S · Sale | −2.34K | $31.76 | $74.44K | 12.9% | 18.15K | 15.81K |
| Total | −3.80K | -$306.32K | ||||||
Performance Stock Units
Common Stock
6K shares
Shares
−6K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Stock Units Direct | Common Stock6K shares | 12/3/2025 | M · Option Exercise | −6K | — | 0.00 |